Y Yang, C Zhao, Y Ye, M Yu, X Qu - Frontiers in Endocrinology, 2020 - ncbi.nlm.nih.gov
Abstract Sodium–glucose co-transporter 2 (SGLT2) inhibitors are a new family of
antidiabetic drugs that reduce blood glucose independent of insulin. In this review, we …